WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticonvulsant-CMAP-v6.cmap, Safety Endpoint has Observation or Assessment, Seizure type has_values Partial seizure, Potential exacerbation of pre-existing seizures documents Seizure occurrence, Observation time period starts_concurrent_ with_start_of Seizure occurrence, FDA Efficacy Endpoints for Anticonvulsant Therapies has_components Secondary efficacy endpoint, Repeated concepts/instances (e.g. Intervention) are denoted by dotted outline, Seizure severity has_pertinent_information Quality of life in epilepsy, Primary efficacy endpoints (e.g. Seizure frequency) are denoted by bold font, Quality of life in epilepsy documents Clinical Global Impression (CGI), Seizure frequency documents Observation time period, Therapeutic Efficacy Point has Observation or Assessment, Observation time period starts_concurrent_ with_start_of Intervention, Observation time period is_documented_in Seizure diary, Primary efficacy endpoint documents Seizure frequency, Primary efficacy endpoint documents Time to first/next seizure, Safety Endpoint has Intervention, Observation time period ends_concurrent_with Defined timepoint, Seizure count is_documented_in Seizure diary, FDA Efficacy Endpoints for Anticonvulsant Therapies has_components Primary efficacy endpoint, Partial seizure refers_to Partial seizure subtype